Latest Articles

Publication Date
Activin A is a functional component of the anti-endometriotic drug Endoferin.

Endometriosis is a prevalent gynecological condition affecting up to 25-40% of women with infertility. Endoferin, a protein complex derived from the bovine ovarian follicles, has demonstrated high efficacy in clinical …

Published: July 31, 2026, midnight
MRI in non-pregnancy-related decidualization of deep pelvic endometriosis: a case report and review of the literature.

Decidual changes in deep pelvic endometriosis (DPE) are extremely rare. During pregnancy, endometriotic activity and symptoms diminish due to hormonal changes, whereas the endometrial lining undergoes decidualization in response to …

Published: July 31, 2026, midnight
Direct IVF versus prior laparoscopic cystectomy for ovarian endometrioma ≥4 cm: cumulative live birth rate and implications for fertility preservation - a retrospective cohort study.

Current guidelines recommend laparoscopic cystectomy for ovarian endometrioma (OMA) ≥4 cm before fertility treatment, yet cystectomy inevitably damages ovarian reserve. While recent large-scale studies have confirmed that cystectomy reduces antimüllerian …

Published: July 31, 2026, midnight
Karyopharm plummets as Xpovio fails in phase 3 trial for endometrial cancer - Seeking Alpha

Karyopharm plummets as Xpovio fails in phase 3 trial for endometrial cancer Seeking Alpha

Published: July 30, 2026, 11:38 p.m.
Karyopharm slumps after Xpovio misses mark in Phase III endometrial cancer study - FirstWord Pharma

Karyopharm slumps after Xpovio misses mark in Phase III endometrial cancer study FirstWord Pharma

Published: July 30, 2026, 9:59 p.m.
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint - TipRanks

Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint TipRanks

Published: July 30, 2026, 9:16 p.m.
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint - tipranks.com

Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint tipranks.com

Published: July 30, 2026, 9:16 p.m.
Update on alleged assault in Portland, Maine - newscentermaine.com

Update on alleged assault in Portland, Maine newscentermaine.com

Published: July 30, 2026, 9:12 p.m.
Pain to Power: Suicide awareness in Lewiston, Maine - newscentermaine.com

Pain to Power: Suicide awareness in Lewiston, Maine newscentermaine.com

Published: July 30, 2026, 8:44 p.m.
Karyopharm endometrial cancer trial misses primary endpoint By Investing.com - Investing.com Nigeria

Karyopharm endometrial cancer trial misses primary endpoint By Investing.com Investing.com Nigeria

Published: July 30, 2026, 8:42 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!